Friday, 13 June 2025
Company’s crop specific speciality product, Croptek, maintained its robust growth trajectory in Q4 FY25 with an exceptional growth rate of 111 % compared to the same quarter of the previous year.
Deepak Fertilisers and Petrochemicals Corporation Limited, one of India’s leading producers of industrial & mining chemicals and fertilisers announced its results for the quarter and full year ended March 31, 2025.
Key Highlights for Q4 FY25 & Full Year:
• Consolidated Revenues: The company demonstrated continued growth, achieving a notable 28 per cent increase in revenues for the quarter, reaching Rs 2,667 crores. Annual revenue growth stood at 18 per cent.
. • EBITDA: EBITDA for Q4 increased by 10 per cent, amounting to Rs 480 Crores. Full-year EBITDA experienced significant growth of 50 per cent, reaching Rs. 1,925 Cr.
• Net Profit: An impressive 21 per cent jump in Q4. Full year PAT doubled, amounting to Rs. 945 Crores.
• Strategic shift from Commodity to Specialty – Remarkable growth visible with revenue share from specialty products improving from 17 per cent in FY24 to 22 per cent in FY25.
• Growth Capex: Strategic investments remain on track – the overall progress in TAN project in Gopalpur is at 75 per cent, and the same for Nitric Acid project in Dahej is at 48 per cent.
• CNB business continue to out-perform – Bulk Fertilizers manufactured sales volume in Q4 surged by 68 per cent YoY, driven by increased adoption of our innovative crop focus nutrient solution.
• TAN Business – Our speciality product, LDAN, saw an impressive 11% YoY growth in sales volume
During FY25, team achieved a significant milestone by surpassing 1 million MT in bulk fertilizer sales and liquidation FY25 PAT Leaps by 102 per cent; Q4 PAT Jumps by 21 per cent.
• In Q4 FY25, manufactured bulk fertilizer volume surged by 68 per cent YoY. For the entire fiscal year, the growth was notable at 55 per cent YoY and totalling 888 KMT, driven by above-normal monsoon rains in the operating region & acceptance of our innovative Crop Focus Solutions. Along with traded bulk, the company has achieved a significant milestone by surpassing 1 million MT in bulk fertilizer sales and liquidation for the first time in a fiscal year, demonstrating the company’s focus and effective execution of strategic products with scale.
• The Innovative-Crop Specific Speciality product, Croptek, maintained its robust growth trajectory in Q4 FY25 with an exceptional growth rate of 111 per cent compared to the same quarter of the previous year, propelling the CNB Vertical from a Commodity Fertilizer Business to a Speciality/Performance Fertilizer Business. Similarly, Smartek, another innovative product, delivered a strong performance in Q4 FY25, recording a YoY growth of 83 per cent.
• Sale of specialty fertilizer Bensulf and water-soluble fertilizers in Q4 was up by 13 per cent YoY and down by 19 per cent QoQ. While sales of manufactured specialty fertilizer grew by 40 per cent YoY, the traded specialty fertilizer volume remained at same level due to fluctuating output prices of vegetables and unseasonal rains damaged Grape crops which reduced consumption of WSF fertilizers.
S.C. Mehta, Chairman and Managing Director of DFPCL, said, “This year has been challenging yet transformative, marked by strategic actions that boosted growth across all product segments. Our financial performance for FY 2024–25 highlights resilience, innovation, and a strong foundation for future success. Our shift from a commodity focus to a specialty and solutions-led company is well underway. Specialty products now comprise 22% of our total operating revenue, up from 17% in FY24, with a 51% YoY growth. Crop-focused fertilizers constitute 30% of our portfolio, reaffirming our commitment to delivering differentiated, customer-first solutions”.
FY 2025–26 is poised to be a pivotal year—one that will prepare us for a major operational leap, with key capacity expansions nearing completion by H2 FY26. These expansions will elevate us as one of the global leaders in Technical Ammonium Nitrate and Building Block Nitric Acid. To ensure financial robustness, we raised Rs 800 crore via CCDs in our subsidiary, DMSL, strengthening our balance sheet and addressing near-term funding needs while maintaining a prudent debt ratio.
